BDMD - רווח עתידי חזוי Baird Medical Corp

Baird Medical Investment (BDMD) is striving for dominance in China's minimally invasive oncology segment and expansion into the US market. The projected profit level confirms this trajectory, with the indicator standing at . Growth is driven by the sale of disposable needles for installed generators, while patents and the complexity of retraining physicians on alternative equipment ensure business stability.
BDMD (Baird Medical Investment Holdings): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The metric is calculated as a dynamic net profit forecast that accounts for currency volatility for exporters. It filters out random market noise, capturing the real impact of conversion on future earnings. For Baird Medical Investment (BDMD), this calculation is critical during its expansion into the US market following FDA approval. Growth in overseas sales of disposable electrodes directly determines changes in projected profit. This chart allows for an objective assessment of the business model's resilience in dollar terms.